Skip to content
Link copied to clipboard

Snider family company details proposed medical-marijuana facility in Northeast Philly

A 125,000-square-foot facility for growing medical marijuana would be built in the Far Northeast under a proposal detailed Wednesday by a company founded by two children and a grandson of Ed Snider, the late founder of the Flyers.

Representatives of Snider Health made a presentation to the Parkwood Civic Association to explain the state's new medical-marijuana law and what the growing facility would entail for the community.

The indoor farm would be at 14515 McNulty Rd., near the Bucks County line, at the end of a cul-de-sac inside Byberry East Industrial Park.

"It's just a presentation to the community at an early stage of the process," Kevin Feeley, a spokesman for Snider Health, said.

The company was founded by Lindy and Jay Snider and Jay's son Jamie. Snider Health has partnered with the Clinic, a medical-marijuana company that operates in Colorado, Nevada, and Illinois, and is seeking a Pennsylvania grower-processor license.

The Pennsylvania Department of Health can issue up to 12 licenses, including two in the southeastern portion of the state. Applications will be accepted from Monday until March 20.

The Snider facility would be built on a 14-acre parcel using union labor, according to Snider Health's PowerPoint presentation. The first phase would provide 40 to 50 jobs.

The presentation highlighted security features of the facility and said it would be open from 8 a.m. to 6 p.m. daily, with two deliveries per day.

Under the law, grower-processor facilities are allowed to sell products only to other grower-processors and dispensaries. No direct sales to patients are permitted.

Lindy Snider, a cannabis-industry entrepreneur and investor, led the presentation to the association, which then voted to support the proposal, Feeley said. The meeting was opened by City Councilman Brian J. O'Neill.

The next step is for Snider Health to submit its application, Feeley said.

Applications will undergo a 90-day review. A top criterion for consideration is the proposed facility's impact on the surrounding community, including a detailed plan of operation and security measures. Applicants must pay a $200,000 fee that is nonrefundable except for rejected projects. There is an additional $10,000 nonrefundable fee for all applicants.

Snider Health hopes to buy the land, owned by the city through the Philadelphia Industrial Development Corp., Feeley said.